ClinicalTrials.gov
public full text
Public Domain
AZD1656 in Transplantation With Diabetes tO PromoTe Immune TOleraNce
complicationsdiabetes-mellitusend-stage-renal-diseaseregulatory-t-cellstype-2type-2-diabetestype-2-diabetes-mellitus
AZD1656 in Transplantation with Diabetes tO PromoTe Immune TOleraNce: a single site, placebo-controlled, double-blind randomised clinical trial of AZD1656 in renal transplant patients with Type 2 diabetes
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- Immune System in Diabetic Kidney Disease#429714
- Efficacy, Safety, Tolerability and Pharmacokinetic (PK) Study of GSK1070806 for the Prevention of Delayed Graft Function (DGF) in Adult Subjects After Renal Transplantation#1310225
- MMF vs. AZA for Kidney Transplantation#882022
- Clinical Study on the Treatment of Type 1 Diabetes With CNK-UT009 Cell Injection#912458
- Immunosuppressive Regimen on Changes in Renal Function and Transplant Rejection Rate in Patients With Lung Transplant#1007781
Record · ID 1214770
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive